Adult Intensive Care Services, The Prince Charles Hospital, Queensland, Australia.
Department of Anaesthesia, Princess Alexandra Hospital, Queensland, Australia.
Ann Card Anaesth. 2021 Oct-Dec;24(4):441-446. doi: 10.4103/aca.ACA_190_20.
To describe current fluid and vasopressor practices after cardiac surgery in Australia and New Zealand cardiothoracic intensive care units (ICU).
This web-based survey was conducted in cardiothoracic ICUs in Australia and New Zealand.
Intensivists, cardiac surgeons, and anesthetists were contacted to complete the online survey that asked questions regarding first and second choice fluids and vasopressors and the tools and factors that influenced these choices.
There were 96 respondents including 51 intensivists, 27 anesthetists, and 18 cardiac surgeons. Balanced crystalloids were the most preferred fluids (70%) followed by 4% albumin (18%) overall and among intensivists and anesthetists; however, cardiac surgeons (41%) preferred 4% albumin as their first choice. The most preferred second choice was 4% albumin (74%). Among vasopressors, noradrenaline was the preferred first choice (93%) and vasopressin the preferred second choice (80%). 53% initiated blood transfusion at a hemoglobin threshold of 70 g/L. Clinical acumen and mean arterial pressure were the most commonly used modalities in determining the need for fluids.
There is practice variation in preference for fluids used in cardiac surgical patients in Australia and New Zealand; however, balanced crystalloids and 4% albumin were the most popular choices. In contrast, there is broad agreement with the use of noradrenaline and vasopressin as first and second-line vasopressors. These data will inform the design of future studies that aim to investigate hemodynamic management post cardiac surgery.
描述澳大利亚和新西兰心胸重症监护病房(ICU)心脏手术后目前的液体和血管加压药物应用实践。
本网络调查在澳大利亚和新西兰的心胸 ICU 中进行。
联系心胸科重症监护医师、心脏外科医师和麻醉医师,完成在线调查,询问关于首选液体和血管加压药物以及影响这些选择的工具和因素的问题。
共有 96 名受访者,包括 51 名重症监护医师、27 名麻醉医师和 18 名心脏外科医师。平衡晶体液是最受欢迎的液体(70%),其次是白蛋白 4%(18%),总体而言以及在重症监护医师和麻醉医师中;然而,心脏外科医师(41%)首选白蛋白 4%作为首选。最受欢迎的二线选择是白蛋白 4%(74%)。在血管加压药物中,去甲肾上腺素是首选的一线药物(93%),血管加压素是首选的二线药物(80%)。53%的人在血红蛋白阈值为 70g/L 时开始输血。临床敏锐度和平均动脉压是确定液体需求最常用的方法。
澳大利亚和新西兰心脏外科患者中对使用的液体的偏好存在实践差异;然而,平衡晶体液和白蛋白 4%是最受欢迎的选择。相比之下,去甲肾上腺素和血管加压素作为一线和二线血管加压药物的使用存在广泛共识。这些数据将为旨在调查心脏手术后血流动力学管理的未来研究提供信息。